Literature DB >> 20553100

Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours.

Eva Tiensuu Janson1, Halfdan Sørbye, Staffan Welin, Birgitte Federspiel, Henning Grønbaek, Per Hellman, Oystein Mathisen, Jann Mortensen, Anders Sundin, Espen Thiis-Evensen, Matti J Välimäki, Kjell Oberg, Ulrich Knigge.   

Abstract

The diagnostic work-up and treatment of patients with neuroendocrine tumours has undergone a major change during the last decade. New diagnostic possibilities and treatment options have been developed. These Nordic guidelines, written by a group with a major interest in the subject, summarises our current view on how to diagnose and treat these patients. The guidelines are meant to be useful in the daily practice for clinicians handling patients with neuroendocrine tumours.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20553100     DOI: 10.3109/0284186X.2010.492791

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  25 in total

1.  Neuroendocrine neoplasms - still a challenge despite major advances in clinical care with the development of specialized guidelines.

Authors:  Stephan Petersenn; Christian A Koch
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

2.  Cost comparison of 111In-DTPA-octreotide scintigraphy and 68Ga-DOTATOC PET/CT for staging enteropancreatic neuroendocrine tumours.

Authors:  Nils F Schreiter; Winfried Brenner; Munenobu Nogami; Ralph Buchert; Alexander Huppertz; Ulrich-Frank Pape; Vikas Prasad; Bernd Hamm; Martin H Maurer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-09-17       Impact factor: 9.236

3.  Current Treatment Options in Gastroenteropancreatic Neuroendocrine Carcinoma.

Authors:  Katharine E H Thomas; Brianne A Voros; J Philip Boudreaux; Ramcharan Thiagarajan; Eugene A Woltering; Robert A Ramirez
Journal:  Oncologist       Date:  2019-01-11

Review 4.  Neuroendocrine Carcinoma of Gall Bladder: A Series of 19 Cases with Review of Literature.

Authors:  Meenakshi Kamboj; Jatin Sundersham Gandhi; Gurudutt Gupta; Anila Sharma; Sunil Pasricha; Anurag Mehta; D Chandragouda; Rupal Sinha
Journal:  J Gastrointest Cancer       Date:  2015-12

Review 5.  The archaic distinction between functioning and nonfunctioning neuroendocrine neoplasms is no longer clinically relevant.

Authors:  Irvin M Modlin; Steven F Moss; Bjorn I Gustafsson; Ben Lawrence; Simon Schimmack; Mark Kidd
Journal:  Langenbecks Arch Surg       Date:  2011-04-27       Impact factor: 3.445

Review 6.  Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advances.

Authors:  Tetsuhide Ito; Hisato Igarashi; Robert T Jensen
Journal:  J Gastroenterol       Date:  2012-08-11       Impact factor: 7.527

7.  Temozolomide as second or third line treatment of patients with neuroendocrine carcinomas.

Authors:  Ingrid H Olsen; Jens B Sørensen; Birgitte Federspiel; Andreas Kjaer; Carsten P Hansen; Ulrich Knigge; Seppo W Langer
Journal:  ScientificWorldJournal       Date:  2012-08-22

Review 8.  Surgical treatment of sporadic pancreatic neuroendocrine tumors: a state of the art review.

Authors:  Sven-Petter Haugvik; Knut Jørgen Labori; Bjørn Edwin; Øystein Mathisen; Ivar Prydz Gladhaug
Journal:  ScientificWorldJournal       Date:  2012-12-10

9.  Incidence and survival of patients with small intestinal neuroendocrine tumours in a Danish NET center.

Authors:  Lise Brehm Hoej; Karen Marie Nykjær; Henning Gronbaek
Journal:  ScientificWorldJournal       Date:  2012-11-28

10.  Improvement in Stress, General Self-Efficacy, and Health Related Quality of Life following Patient Education for Patients with Neuroendocrine Tumors: A Pilot Study.

Authors:  Trude Haugland; Marijke Veenstra; Morten H Vatn; Astrid K Wahl
Journal:  Nurs Res Pract       Date:  2013-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.